UNSPSC 51263003: Trimazosin

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C20H29N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 31L760807H, chemically known as 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-1-piperazinecarboxylic acid, 2-hydroxy-2-methylpropyl ester but generally known as trimazosin, which bears US NIH Compound Identifier 37264. European Medicines Agency schedules Trimazosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11298MIG.

UNSPSC 51263003 Trimazosin, a Commodity code, sees minimal recent state and local procurement activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB60459723LAS — is actually soliciting naloxone and safe drug deactivation systems for community health delivery, not trimazosin, indicating a significant mismatch between the code assignment and the work being procured. Trimazosin itself is a pharmaceutical product with limited visibility in state and local government purchasing patterns based on available records.

Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023, calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement requires electronic bid submission through the county's e-Procurement Portal, with vendors responsible for all shipping and delivery costs. Bidders must comply with drug-free workplace certification, E-Verify requirements, and specific insurance coverages, and the contract carries a three-month probationary period with potential FEMA funding subject to federal compliance obligations. Given the code's apparent misapplication to pharmaceutical procurement outside trimazosin's scope and the sparse activity record, this code warrants minimal business development focus currently.